Search Results 381-390 of 18190 for Immunode

1. A Study to Evaluate Intracoronary CD34+ Cell Administration in Patients With Early Coronary Atherosclerosis - Mayo Clinic

   Subjects with known severe immunodeficiency states (AIDS). Significant coronary artery disease on coronary angiogram. Cirrhosis requiring active medical ...

2. A Study of Niraparib Combined with Pembrolizumab (MK-3475) in Patients who have Triple-Negative Breast Cancer or Ovarian Cancer - Mayo Clinic

   Immunodeficiency or is receiving systemic steroid therapy or any other form of immunosuppressive therapy within 7 days prior to the first dose of study ...

3. Publications - Paschalis Vergidis, M.D., M.S. - Mayo Clinic

   ... immunodeficiency virus infection. Infect Dis Clin North Am. 2009 Jun; 23 (2):295-308. View PubMed; Vergidis PI, Falagas ME. New antibiotic agents for ...

4. Safety and Efficacy Study of MLN0128 in Combination With Exemestane or Fulvestrant in Postmenopausal Women With ER/PR+ Metastatic Breast Cancer - Mayo Clinic

   Known human immunodeficiency virus infection. History of any of the following within the last 6 months before administration of the first dose of MLN0128 ...

5. Breast rash Causes - Mayo Clinic

   Atopic dermatitis, eczema, and noninfectious immunodeficiency disorders. In: Andrews' Diseases of the Skin Clinical Atlas. 2nd ed. Elsevier; 2023. https ...

6. A Clinical Study to Test How Effective and Safe GLPG1690 is for Subjects With Idiopathic Pulmonary Fibrosis (IPF) When Used Together With Standard Medical Treatment

   A current immunosuppressive condition (e.g. human immunodeficiency virus [HIV] infection, congenital, acquired, medication-induced). Positive blood testing ...

7. Point of Care Lateral Flow Assay for Coccidioidomycosis - Mayo Clinic

   ... immunodeficiency) or by medications (such as but not limited to receipt of rituximab). Unable or unwilling to consent to study. Participating Mayo Clinic ...

8. Ivosidenib, Nivolumab, and Ipilimumab Combination in Previously Treated Subjects with Nonresectable or Metastatic IDH1-Mutant Cholangiocarcinoma - Mayo Clinic

   Known immunodeficiency or HIV, hepatitis B, or hepatitis C infection. Antibody to hepatitis B or C without evidence of active infection may be allowed ...

9. ATHN 11: A Study of Liver Transplantation Outcomes - Mayo Clinic

   ... immunodeficiency virus (HIV)-infected patients because of reportedly poor outcomes. This prospective, multicenter US cohort study compared patient and graft ...

10. Study Of Lurbinectedin In Combination With Doxorubicin Versus Doxorubicin Alone As First-line Treatment In Participants With Metastatic Leiomyosarcoma - Mayo Clinic

    Patients with any immunodeficiency, including those known to be infected by human immunodeficiency virus (HIV);. Chronic active hepatitis or cirrhosis. For ...